STMicroelectronics NV (STM) Stock Price Today
Aura AI Summary
Key Stats
- $54.67BMarket Cap
- -Volume
- FinancialsSector
- $79.9152W High
- $21.2052W Low
- -Typical Hold Time
- $52.88BEnterprise Value
- 0.58%Div Yield
- -Trading Activity
Track STMicroelectronics NV (STM) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, STMicroelectronics NV has traded between a low of $21.2 and a high of $79.91, highlighting its annual price range. Buy and sell STMicroelectronics NV shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About STMicroelectronics NV
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Most Recent News
Urology devices market to double to $80B by 2035, driven by robotic surgery and kidney disease treatment.
The global urology devices market, valued at $39.23 billion in 2025, is projected to grow at a CAGR of 7.35% to reach $80 billion by 2035. Growth is fueled by rising demand for robotic-assisted surgeries, kidney disease management, and minimally inva...

Quantum photonics market to hit $14.12B by 2035, driven by quantum computing and secure communication tech.
The global quantum photonics market, valued at $0.77 billion in 2025, is projected to grow at a CAGR of 33.79% to reach $14.12 billion by 2035. Growth is fueled by the commercialization of quantum computing, secure quantum communication networks, and...

Positive Phase 2a data for Namodenoson in advanced pancreatic cancer accepted for presentation at ESMO 2026.
Can-Fite BioPharma announced that positive Phase 2a study results of Namodenoson, a drug for advanced pancreatic ductal adenocarcinoma, have been accepted for presentation at the ESMO Congress 2026. The study showed durable disease stabilization and ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.